Jonathan Ostrem, 29

A protein called ras, which spurs the growth of many cancers, has been beyond the reach of drug hunters because it has a normal form that's needed and potential drugs hit that, too. Ostrem created a drug that blocks only the bad actor. A company, Wellspring Biosciences, has been started to commercialize the work.